Stilla Technologies

Stilla^® Crystal Digital PCR™ technology for absolute ­quantification of nucleic acids is based on ­cutting-edge microfluidic technology that ­integrates the digital PCR process in a single consumable, ­reducing the hands-on time and interaction, so users can simply insert the sample and walk away.

The sample is partitioned using a network of microchannels into a large array of individual droplets, also called a droplet crystal. Owing to the next-generation Crystal Digital PCR™ technology, the droplets partitioned are identical in size- ­yielding results you can trust. PCR then ­amplifies the ­fluorescent target in the droplets which can be read for ­absolute quantification the nucleic acids.

With a combination of powerful imaging, the flexibility to use up to 3 detection channels, and a proprietary software for analysis, Crystal Digital PCR™ is designed to offer an unmatched level of confidence in the digital PCR ­measurement.

The Naica^® System

Get absolute quantification of multiple genetic targets in a single run

Digital PCR (dPCR) is a powerful tool used for the precise and highly sensitive quantification of nucleic acids.

The naica^® system is an easy-to-use dPCR platform that harnesses cutting-edge microfluidic technology to integrate the dPCR workflow onto a single consumable chip. The technology, known as Crystal Digital PCR™, partitions samples into a large array of thousands of individual droplet crystals – each its own reaction compartment – before amplifying nucleic acid molecules in each droplet crystal. These reactions are tagged with fluorophores to be read using up to six different fluorescence light channels.

This makes for a fast and simple workflow that provides even more sensitivity while reducing time to results and saving precious sample.